SIRION Biotech
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
125 Cambridgepark Dr Ste 301, Cambridge,...Phone Number
(857) 284-1844Website
www.sirion-biotech.comRevenue
$7.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About SIRION Biotech
Revvity specializes in viral vector technologies and services for gene delivery, catering to innovators in cell therapy, gene therapy, and vaccination. With over 20 years of expertise, they offer a comprehensive range of viral vector products, including adeno-associated viruses, lentiviruses, and adenoviruses, aimed at accelerating research and development processes. Their services include viral vector development, manufacturing, and enhancements like LentiBOOST to improve transduction efficiency. Revvity partners with pharmaceutical and biotech organizations to provide tailored solutions for various stages of discovery and development.Explore more
SIRION Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SIRION Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once SIRION Biotech has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at SIRION Biotech
Check out if SIRION Biotech is spiking on competitors!
Earning: See what the market has to say on SIRION Biotech recently announced quarterly report
Click to see if SIRION Biotech had a recent Job posting/layoffs
Product Launch: Get notified when SIRION Biotech launches new products
Check if SIRION Biotech has recently received funding, and reach out quickly before it becomes old news!
SIRION Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at SIRION Biotech
Find 3 more new buyers
Compare Similar Companies to SIRION Biotech
Compare insights from companies similar to SIRION Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
SIRION Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SIRION Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SIRION Biotech.
SIRION Biotech Tech Stack
A closer look at the technologies used by SIRION Biotech
See more technologies
SIRION Biotech News & Media
PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader SIRION Biotech
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer has entered an agreement to acquire SIRION Biotech GmbH, a provider of viral vector-based technologies for cell and gene therapies.SIRION Biotech Hosts “Engineering AAV Lead Vectors for Gene Therapy” Webinar on March 16 at 9 a.m. EST/3 p.m. CET
Dr. Michael Salomon, Senior Vice President, Development, and Dr. Irene Ferreira, Head of Clinical Support, Cell and Gene Therapy of SIRION Biotech will discuss optimizing vector design at R&D and preclinical stages for improved safety and efficacy. (PRWeb March 11, 2021) Read the full story at https://www.prweb.com/releases/sirion_biotech_hosts_engineering_aav_lead_vectors_for_gene_therapy_webinar_on_march_16_at_9_a_m_est_3_p_m_cet/prweb17787922.htmSIRION Biotech Announces Collaboration with Sanofi to Innovate Gene Therapy Treatments with Improved Adeno-Associated Virus Capsids
MUNICH--(BUSINESS WIRE)-- #AAV--SIRION Biotech announced that it signed a license and collaboration agreement with Sanofi.SIRION Biotech GmbH Licensed Its LentiBOOST™ Transduction Technology to Cellectis
MUNICH & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #Allogeneic--SIRION Biotech GmbH licensed its LentiBOOST™ transduction technology to Cellectis.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SIRION Biotech
Sign Up For FreeTo access detailed company insights
Revvity specializes in viral vector technologies and services for gene delivery, catering to innovators in cell therapy, gene therapy, and vaccination. With over 20 years of expertise, they offer a comprehensive range of viral vector products, including adeno-associated viruses, lentiviruses, and adenoviruses, aimed at accelerating research and dev... Read More
